RxDoctor Payments Data

Debra Bowling, APRN

Family · Dayton, OHNPI 1326517947

Payments from drug & device makers

$419in general payments, 2019–2025

Across 24 payments — averaging $17.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$94
  • Otsuka America Pharmaceutical, Inc.$62
  • Alkermes, Inc.$54
  • Lilly USA, LLC$52
  • Novo Nordisk$40
  • Xeris Pharmaceuticals, Inc.$23
  • plus $95 from 5 others

What the payments were for

  • Food & beverage$419100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$419 in reported general payments places this provider in the 50th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$291
Medicare patients
15
Services billed
42

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin60$90,873
JanuviaSitagliptin Phosphate45$55,231
TrulicityDulaglutide41$49,871
Spiriva RespimatTiotropium Bromide35$29,539
EliquisApixaban25$26,790
MyrbetriqMirabegron14$11,320
Advair HfaFluticasone Propion/Salmeterol13$5,733
Incruse ElliptaUmeclidinium Bromide16$5,461
Lantus SolostarInsulin Glargine,hum.Rec.Anlog70$4,798
Insulin Lispro Kwikpen U-100Insulin Lispro16$4,231
Albuterol Sulfate HfaAlbuterol Sulfate162$3,495
SymbicortBudesonide/Formoterol Fumarate12$3,303
Fluticasone-SalmeterolFluticasone Propion/Salmeterol18$2,511
Divalproex Sodium14$2,369
Atorvastatin Calcium326$2,349

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat$15$120,41295 claims
Lilly USA, LLCTrulicity$52$49,87141 claims
GSKIncruse Ellipta$18$5,46116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 6,812 family providers in Ohio.

Other family in Dayton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →